Technical Analysis for QTRX - Quanterix Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 14.08 | 1.44% | 0.20 |
QTRX closed down 2.8 percent on Monday, January 30, 2023, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 1.44% | |
MACD Bearish Signal Line Cross | Bearish | 1.44% | |
20 DMA Support | Bullish | 1.44% | |
NR7 | Range Contraction | 1.44% | |
NR7-2 | Range Contraction | 1.44% | |
Narrow Range Bar | Range Contraction | 1.44% | |
Down 3 Days in a Row | Weakness | 1.44% | |
Gapped Down | Weakness | 1.44% | |
200 DMA Support | Bullish | -1.40% | |
NR7 | Range Contraction | -1.40% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
200 DMA Resistance | about 3 hours ago |
10 DMA Resistance | about 3 hours ago |
Rose Above Previous Day's High | about 3 hours ago |
Rose Above 200 DMA | about 3 hours ago |
Up 3% | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/27/2023
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Biomarkers Urology Cardiology Neurology Quality Of Life Digital Health
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Biomarkers Urology Cardiology Neurology Quality Of Life Digital Health
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.98 |
52 Week Low | 6.31 |
Average Volume | 288,759 |
200-Day Moving Average | 14.19 |
50-Day Moving Average | 13.17 |
20-Day Moving Average | 13.76 |
10-Day Moving Average | 14.31 |
Average True Range | 0.87 |
RSI | 51.92 |
ADX | 29.01 |
+DI | 27.31 |
-DI | 14.11 |
Chandelier Exit (Long, 3 ATRs) | 12.94 |
Chandelier Exit (Short, 3 ATRs) | 14.76 |
Upper Bollinger Bands | 15.10 |
Lower Bollinger Band | 12.42 |
Percent B (%b) | 0.54 |
BandWidth | 19.48 |
MACD Line | 0.38 |
MACD Signal Line | 0.39 |
MACD Histogram | -0.0104 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.51 | ||||
Resistance 3 (R3) | 14.54 | 14.36 | 14.41 | ||
Resistance 2 (R2) | 14.36 | 14.20 | 14.35 | 14.37 | |
Resistance 1 (R1) | 14.12 | 14.10 | 14.03 | 14.09 | 14.33 |
Pivot Point | 13.94 | 13.94 | 13.90 | 13.93 | 13.94 |
Support 1 (S1) | 13.70 | 13.78 | 13.61 | 13.67 | 13.43 |
Support 2 (S2) | 13.52 | 13.68 | 13.51 | 13.39 | |
Support 3 (S3) | 13.28 | 13.52 | 13.36 | ||
Support 4 (S4) | 13.25 |